These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

430 related items for PubMed ID: 20503524

  • 1. Prevention of parenteral nutrition-associated liver disease: role of omega-3 fish oil.
    Fallon EM, Le HD, Puder M.
    Curr Opin Organ Transplant; 2010 Jun; 15(3):334-40. PubMed ID: 20503524
    [Abstract] [Full Text] [Related]

  • 2. Prevention of parenteral nutrition-associated liver disease: lipid minimization.
    Cober MP, Teitelbaum DH.
    Curr Opin Organ Transplant; 2010 Jun; 15(3):330-3. PubMed ID: 20386446
    [Abstract] [Full Text] [Related]

  • 3. Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: the Boston experience.
    de Meijer VE, Gura KM, Le HD, Meisel JA, Puder M.
    JPEN J Parenter Enteral Nutr; 2009 Jun; 33(5):541-7. PubMed ID: 19571170
    [Abstract] [Full Text] [Related]

  • 4. Pediatric parenteral nutrition-associated liver disease and cholestasis: Novel advances in pathomechanisms-based prevention and treatment.
    Orso G, Mandato C, Veropalumbo C, Cecchi N, Garzi A, Vajro P.
    Dig Liver Dis; 2016 Mar; 48(3):215-22. PubMed ID: 26698410
    [Abstract] [Full Text] [Related]

  • 5. Parenteral fish oil monotherapy in the management of patients with parenteral nutrition-associated liver disease.
    de Meijer VE, Gura KM, Meisel JA, Le HD, Puder M.
    Arch Surg; 2010 Jun; 145(6):547-51. PubMed ID: 20566974
    [Abstract] [Full Text] [Related]

  • 6. Anti-inflammatory and anti-fibrotic profile of fish oil emulsions used in parenteral nutrition-associated liver disease.
    Pastor-Clerigues A, Marti-Bonmati E, Milara J, Almudever P, Cortijo J.
    PLoS One; 2014 Jun; 9(12):e115404. PubMed ID: 25502575
    [Abstract] [Full Text] [Related]

  • 7. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury.
    Puder M, Valim C, Meisel JA, Le HD, de Meijer VE, Robinson EM, Zhou J, Duggan C, Gura KM.
    Ann Surg; 2009 Sep; 250(3):395-402. PubMed ID: 19661785
    [Abstract] [Full Text] [Related]

  • 8. Effect of omega-3 polyunsaturated fatty acids to reverse biopsy-proven parenteral nutrition-associated liver disease in adults.
    Xu Z, Li Y, Wang J, Wu B, Li J.
    Clin Nutr; 2012 Apr; 31(2):217-23. PubMed ID: 22035955
    [Abstract] [Full Text] [Related]

  • 9. The use of Omegaven in treating parenteral nutrition-associated liver disease.
    Park KT, Nespor C, Kerner J.
    J Perinatol; 2011 Apr; 31 Suppl 1():S57-60. PubMed ID: 21448206
    [Abstract] [Full Text] [Related]

  • 10. Inpatient outcomes of preterm infants receiving ω-3 enriched lipid emulsion (SMOFlipid): an observational study.
    Choudhary N, Tan K, Malhotra A.
    Eur J Pediatr; 2018 May; 177(5):723-731. PubMed ID: 29445923
    [Abstract] [Full Text] [Related]

  • 11. Reversal of parenteral nutrition-associated liver disease with a fish oil-based lipid emulsion (Omegaven) in an adult dependent on home parenteral nutrition.
    Burns DL, Gill BM.
    JPEN J Parenter Enteral Nutr; 2013 Mar; 37(2):274-80. PubMed ID: 22683685
    [Abstract] [Full Text] [Related]

  • 12. Treatment of parenteral nutrition-associated liver disease: the role of lipid emulsions.
    Nandivada P, Carlson SJ, Chang MI, Cowan E, Gura KM, Puder M.
    Adv Nutr; 2013 Nov; 4(6):711-7. PubMed ID: 24228202
    [Abstract] [Full Text] [Related]

  • 13. Elimination of soybean lipid emulsion in parenteral nutrition and supplementation with enteral fish oil improve cholestasis in infants with short bowel syndrome.
    Rollins MD, Scaife ER, Jackson WD, Meyers RL, Mulroy CW, Book LS.
    Nutr Clin Pract; 2010 Apr; 25(2):199-204. PubMed ID: 20413701
    [Abstract] [Full Text] [Related]

  • 14. Lipid emulsions in the treatment and prevention of parenteral nutrition-associated liver disease in infants and children.
    Nandivada P, Fell GL, Gura KM, Puder M.
    Am J Clin Nutr; 2016 Feb; 103(2):629S-34S. PubMed ID: 26791189
    [Abstract] [Full Text] [Related]

  • 15. Mechanisms for the effects of fish oil lipid emulsions in the management of parenteral nutrition-associated liver disease.
    Nandivada P, Cowan E, Carlson SJ, Chang M, Gura KM, Puder M.
    Prostaglandins Leukot Essent Fatty Acids; 2013 Sep; 89(4):153-8. PubMed ID: 23602846
    [Abstract] [Full Text] [Related]

  • 16. Vitamin E in New-Generation Lipid Emulsions Protects Against Parenteral Nutrition-Associated Liver Disease in Parenteral Nutrition-Fed Preterm Pigs.
    Ng K, Stoll B, Chacko S, Saenz de Pipaon M, Lauridsen C, Gray M, Squires EJ, Marini J, Zamora IJ, Olutoye OO, Burrin DG.
    JPEN J Parenter Enteral Nutr; 2016 Jul; 40(5):656-71. PubMed ID: 25596209
    [Abstract] [Full Text] [Related]

  • 17. The evolving use of intravenous lipid emulsions in the neonatal intensive care unit.
    Calkins KL, Puder M, Gura K.
    Semin Perinatol; 2019 Nov; 43(7):151155. PubMed ID: 31331633
    [Abstract] [Full Text] [Related]

  • 18. Intravenous Lipid Emulsions in the Prevention and Treatment of Liver Disease in Intestinal Failure.
    Rochling FA.
    Nutrients; 2021 Mar 10; 13(3):. PubMed ID: 33801970
    [Abstract] [Full Text] [Related]

  • 19. Use of Fish Oil Intravenous Lipid Emulsions as Monotherapy in the Pediatric Intestinal Failure Patient: Beyond the Package Insert.
    Gura KM, Calkins KL, Puder M.
    Nutr Clin Pract; 2020 Feb 10; 35(1):108-118. PubMed ID: 31549454
    [Abstract] [Full Text] [Related]

  • 20. Improved outcome in neonatal short bowel syndrome using parenteral fish oil in combination with ω-6/9 lipid emulsions.
    Angsten G, Finkel Y, Lucas S, Kassa AM, Paulsson M, Lilja HE.
    JPEN J Parenter Enteral Nutr; 2012 Sep 10; 36(5):587-95. PubMed ID: 22275330
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.